The tumor necrosis factor-alpha (TNFα) G308A gene polymorphism has been implicated in susceptibility to essential hypertension (EH), but study results are still controversial.
Objective and Methods
The present meta-analysis is performed to investigate the relationship between the TNFα G308A gene polymorphism and EH. Electronic databases were searched and seven separate studies on the association of the TNF α G308A gene polymorphism with EH were analyzed. The meta-analysis involved 1092 EH patients and 1152 controls. The pooled odds ratios (ORs) and their corresponding 95% confidence interval (CI) were calculated by a fixed or random effect model.
A significant relationship between the TNFα G308A gene polymorphism and EH was found in an allelic genetic model (OR: 1.45, 95% CI: 1.17 to 1.80, P = 0.0008), a recessive genetic model (OR: 3.181, 95% CI: 1.204 to 8.408, P = 0.02), and a homozygote model (OR: 3.454, 95% CI: 1.286 to 9.278, P = 0.014). No significant association between them was detected in both a dominant genetic model (OR: 1.55, 95% CI: 0.99 to 2.42, P = 0.06) or a heterozygote genetic model (OR: 1.45, 95% CI: 0.90 to 2.33, P = 0.13).
Citation: Li Y-y (2012) Tumor Necrosis Factor-Alpha G308α Gene Polymorphism and Essential Hypertension: A Meta-Analysis Involving 2244 Participants. PLoS ONE 7(4): e35408. https://doi.org/10.1371/journal.pone.0035408
Editor: D. William Cameron, University of Ottawa, Canada
Received: January 5, 2012; Accepted: March 15, 2012; Published: April 19, 2012
Copyright: © 2012 Yan-yan Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by the National Natural Science Foundation of China (NSFC 81100073 to YL) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The author has declared that no competing interests exist.
There are about one billion essential hypertension (EH) patients in the world, and the current EH morbidity in China is about 11.8%. Statistical data from the Ministry of Health of the People's Republic of China indicate that the incidence of cerebrovascular diseases increases up to two million cases each year, and 60% of which are associated with EH. Among EH sufferers, 1.5 million die of stroke every year. The Framingham heart study has shown that in the United States, the EH risk in 55-year-old normotension individuals is 90% throughout their lives.
EH is a common disease influenced by polygenic and environmental factors. Finding a new gene associated with EH will help clarify the pathogenesis of EH and provide a new therapeutic strategy. The pathogenesis of EH is not limited to cardiovascular areas and is also related to immunology as well as heredity . Inflammation plays a key role in the development of such cardiovascular diseases as atherosclerosis, diabetes, and so on . The association of inflammation with EH has received increased attention for the past few years.
Tumor necrosis factor-alpha (TNF α), the inflammation promoter, is secreted primarily by mononuclear phagocyte cells. TNF α induces endothelial cells to secrete vasoactive substances via the autocrine or paracrine pattern, which leads to vasorelaxation or vasoconstriction, and ultimately, to the regulation of blood pressure (BP) . The TNF α gene is located in the major histocompatibility complex III region on chromosome 6p21.3. Recent research has revealed that TNF α gene polymorphisms are mostly focused on the probable influence of the promoter district on the expression of the TNFα gene. The TNFα gene polymorphism is also involved in infectious diseases, metabolic syndrome, stroke, hyperuricemia, and so on –.
In 2003, Bogdanski et al.  found that the serum TNFα level in EH patients was much higher than in normotensive individuals, and gradually increased with the EH process. In 2010, Mazor et al.  found a similar phenomenon in mice. The 308th TNF α gene promoter can influence TNF α expression at the transcription level . Although research on TNFα G308A gene polymorphism and EH is relatively limited, the results are still controversial –.
Hence, the present meta-analysis, which involved 2244 subjects, was performed to generate a valuable conclusion on the association between the TNFα G308A gene polymorphism and EH (Supporting Information S1).
Materials and Methods
Publication search and inclusion criteria
The included studies were retrieved from the electronic databases PubMed, Embase, Web of Science, China Biological Medicine Database, and China National Knowledge Infrastructure using the search terms “tumor necrosis factor-alpha,” “polymorphism,” “hypertension,” “gene,” and “Chinese”. The last research was updated on February 5, 2012.
The inclusion criteria were as follows: a) evaluation of the TNFα G308A gene polymorphism and EH in a Chinese population, b) EH diagnosis in accordance with the EH diagnosis requirements of the World Health Organization established in 1999, c) subjects had a systolic BP≥140 mmHg or a diastolic BP≥90 mmHg, and d) subjects had no secondary hypertension.
All data were collected according to a standard protocol. Studies that were repeated, of poor research quality, did not meet the inclusion criteria, and provided little information or insufficient data were excluded. Table 1 lists the characteristics of the extracted data, including the name of the first author, publication date, region, number of genotypes, genotype, study design, matching criteria, total number of cases, and controls. The study regions comprised China, Korea, and Argentina. China and Korea were classified into the Asian subgroup, and Argentina into the American subgroup.
The association between the TNFα G308A gene polymorphism and EH was compared by the odds ratio (OR) and the corresponding 95% confidence interval (CI) between the EH and control groups. The heterogeneity of between-studies was determined by the Chi-square-based Q-test, and the significance was fixed at the level P<0.05 . The inconsistency index I2 was also calculated to evaluate the variation caused by the heterogeneity. A high value of I2 indicated a higher probability of the existence of heterogeneity (I2 = 0% to 25%, no heterogeneity; I2 = 25% to 50%, moderate heterogeneity; I2 = 50% to 75%, large heterogeneity; and I2 = 75% to 100%, extreme heterogeneity). If there was heterogeneity among the studies, the random-effects model was used to estimate the pooled OR by the DerSimonian and Laird method . Otherwise, the pooled OR was estimated by the fixed-effect model (the Mantel-Haenszel method) . The significance of the pooled OR was determined by the Z test and the significance was set at P<0.05. Fisher's exact test was used to assess the Hardy-Weinberg equilibrium and the significance was set at P<0.05. Potential publication bias was estimated using a funnel plot. Egger's linear regression test was used to evaluate the funnel plot asymmetry on the natural logarithmic scale of the OR (P<0.05 was statistically significant) . The Review Manager 4.2 software and the STATA 11.0 software were used to perform statistical analyses (StataCorp, College Station, TX). Recessive genetic and heterozygote models were analyzed by the STATA 11.0 software, and the other models were analyzed by the Review Manager 4.2 software.
Studies and populations
Seventeen papers were gathered from the literature research, among which seven papers were eligible based on the study selection criteria. Of the ten excluded studies, one paper was a repeated publication, three papers were reviews, and five manuscripts were unrelated to the TNFα G308A gene polymorphism. One paper was excluded because it deviated from the Hardy-Weinberg equilibrium (Figure 1, Supporting Information S2). The data of the seven included studies were obtained from 1092 EH patients and 1152 controls from three districts (Table 1). The ORs differed among the seven studies; some of which indicated that the A allele increased EH risk, whereas the others reported no association between the TNFα G308A gene polymorphism and EH risk. Hence, a composite analysis of the study results was performed to draw a reasonable conclusion.
A significant association between the TNFα G308A gene polymorphism and EH was found in an allelic genetic model (OR: 1.45, 95% CI: 1.17 to 1.80, P = 0.0008, Pheterogeneity = 0.10), a recessive genetic model (OR: 3.181, 95% CI: 1.204 to 8.408, P = 0.02, Pheterogeneity = 0.417), and a homozygote model (OR: 3.454, 95% CI: 1.286 to 9.278, P = 0.014, Pheterogeneity = 0.467). The results from the three genetic models were positive and the heterogenetity between the invidual studies did not exist which indicated that there was an intensively positive association between TNFα 308A allele and EH risk.
No significant association between them was detected in both a dominant genetic model (OR: 1.55, 95% CI: 0.99 to 2.42, P = 0.06, Pheterogeneity = 0.003) or a heterozygote genetic model (OR: 1.45, 95% CI: 0.90 to 2.33, P = 0.13, Pheterogeneity = 0.001) (Table 2, Figures 2, 3, and 4). Although the result of the dominant genetic model was negative, the P value was 0.06 which suggested that the association was marginal between them. Supporting that the sample size was further expanded, the association between TNFα 308A allele and EH risk might be positive. Similarly, the same result might also be deduced by the heterozygote genetic model in the future study.
The publication bias of the included studies was assessed by the funnel plot and Egger's test. The funnel plot showed no apparent evidence of publication bias (Figure 5). There was also no significant difference in the Egger's test for the allelic genetic model, which suggested that the probability of publication bias was low in the present meta-analysis (T = 0.28, P = 0.792).
The present study suggested a significant association between the TNFα G308A gene polymorphism and EH in an allelic genetic model (OR: 1.45), a recessive genetic model (OR: 3.181), and a homozygote genetic model (OR: 3.454). The A allele of the TNFα G308A gene may be the susceptibility gene for EH. This result was the strength of this meta-analysis.
EH is one of the principally harmful disorders to public health. EH morbidity gradually increases annually, and the EH onset age becomes younger on the average. Apart from heredity, dietary, psychological, and neuroendocrinal factors, inflammation also plays an important part in the EH mechanism . EH is a genetic heterogeneity disease, and the genetic factor contributes 30% to 50% to the variation in BP . Increased serum inflammatory factor levels of TNFα, interleukin-6, and adhesion molecules suggest that inflammation has an important function in the EH process .
TNFα is a sensitive inflammation indicator. It has a direct injury effect on endothelial cells depending on the dosage. At low concentration levels, TNF α is a short-distance regulatory factor that can induce target cells to produce cytokines and antibodies. At high concentration levels, TNFα can enter the blood and exhibit hormone-like effects. Increased TNFα exerts an immediate cytotoxic effect by facilitating neutrophilic granulocyte degranulation, oxidative metabolism, and accelerated lipid peroxidation. It can destroy the structural integrity and function of endothelial cells, causing an imbalance in endothelial cells that secrete active substances. Decreased synthesis and release of vasodilators as nitric oxide and increased secretion of vasoconstrictors as endothelin and prostaglandin indirectly expedite vasoconstriction as well as elevate peripheral resistance and BP. A low perfusion condition caused by the capillary contraction of the EH target organ also ensues .
The A allele of the TNFα G308A gene increases TNFα transcription activity and the serum TNF α level. This allele has also been associated with obesity, type 2 diabetes mellitus, coronary artery disease, serum C reactive protein, and insulin resistance . The present meta-analysis confirms that the A allele of the TNFα G308A gene increases EH susceptibility.
The divergence among the different research results may be due to the following limitations:
- Ethnic differences. In 2001, Ito et al.  found that TNF-alpha may play a role in modulating BP and low-density-lipoprotein cholesterol in Japanese women. However, in 2002, Krikovszky et al.  reported that the TNF-alpha-308A allele carrier state appears to be associated with the low systolic and diastolic BP values in diabetic adolescents in Hungary. In 2007, Yoo et al.  found that the TNF-alpha-308G allele carrier is associated with increased EH risk in Koreans. In China, Guo  and Peng et al.  found that a positive relationship between EH and the TNF-alpha-308A allele. Sookoian et al. also confirmed this point in Argentina . As the ethnic differences among the individual studies existed, the population was devided into two subgroups as Asian and American subgroup to analyze the results respectively.
- Geographic isolation. In the seven studies included in the current meta-analysis, the pressure of natural selection caused an idiopathic gene polymorphism distribution structure. This phenomenon can be attributed to the fact that the research subjects in the seven studies came from different districts.
- Sample size. In the current meta-analysis, the total sample size was relatively small and the results may be unclear. Increased sample size is recommended in further research.
Finally, the present meta-analysis suggests that the frequency distribution of the A allele of the TNFα G308A gene may be predisposed to EH. Due to the aforementioned limitations, further investigations should be conducted to verify these findings.
PRISMA 2009 Checklist.
We thank all our colleagues working in the Department of Geriatrics, the First Affiliated Hospital of Nanjing Medical University.
Conceived and designed the experiments: YL. Performed the experiments: YL. Analyzed the data: YL. Contributed reagents/materials/analysis tools: YL. Wrote the paper: YL.
- 1. Won JH, Ehret G, Chakravarti A, Olshen RA (2011) SNPs and other features as they predispose to complex disease: genome-wide predictive analysis of a quantitative phenotype for hypertension. PLoS One 6: e27891.
- 2. Mathieu P, Poirier P, Pibarot P, Lemieux I, Després JP (2009) Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 53: 577–584.
- 3. Kahaleh MB, Fan PS (1997) Effect of cytokines on the production of endothelin by endothelial cells. Clin Exp Rheumatol 15: 163–167.
- 4. Yee LJ, Tang J, Herrera J, Kaslow RA, van Leeuwen DJ (2000) Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection. Genes Immun 1: 386–390.
- 5. Sookoian S, García SI, Gianotti TF, Dieuzeide G, González CD, et al. (2005) The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with hypertension in adolescents harboring the metabolic syndrome. Am J Hypertens 18: 1271–1275.
- 6. Liu ZW, Li JC, Li MX, Chen SQ (2009) Study on TNFα-238G/A polymorphisnis in patients with cerebral infarction. Anat Res, 31: 259–262.
- 7. Li CQ, Wang F, Wang YG (2010) The Association of the TNF-α Gene of G-308A Genotypes in Chinese hyperuricemia patients and cardiovascular risk factors. Molecular Cardiology of China 10: 29–32.
- 8. Bogdański P, Kujawska-Łuczak M, Łacki J, Pupek-Musialik D (2003) Evaluation of selected interleukins, tumor necrosis factor, insulin and leptin in obese patients with hypertension. Pol Merkur Lekarski15:347–349; discussion 349–51:
- 9. Mazor R, Itzhaki O, Sela S, Yagil Y, Cohen-Mazor M, et al. (2010) Tumor necrosis factor-alpha: a possible priming agent for the polymorphonuclear leukocyte-reduced nicotinamide-adenine dinucleotide phosphate oxidase in hypertension. Hypertension 55: 353–362.
- 10. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94: 3195–3199.
- 11. Sheu WH, Lee WJ, Lin LY, Chang RL, Chen YT (2001) Tumor necrosis factor alpha −238 and −308 polymorphisms do not associate with insulin resistance in hypertensive subjects. Metabolism 50: 1447–1451.
- 12. Li H (2003) Clinical and Basic Research on Essential Hypertensives with Insulin Resistance. Shanghai: Shanghai Second Medical University Press. 37 p.
- 13. Wu XB, Zhou SH (2004) Association of the tumor necrosis factor-alpha gene G308A promoter polymorphism with essential hypertension. Chin J Hyper 12: 415–418.
- 14. Yoo CS, Hwang WJ, Hong SH, Lee HJ, Jeong HJ, et al. (2007) Relationship between iris constitution analysis and TNF-alpha gene polymorphism in hypertensives. Am J Chin Med 35: 621–629.
- 15. Guo LW, Wu HY, Huang YM, Li R, Wang KJ, et al. (2009) Correlation between tumor necrosis factor α and β gene polymorphisms and essential hypertension. Journal of Xinxiang Medical College 26: 352–354.
- 16. Peng CY, Zhou CL, He QZ (2011) Association of TNF-α gene −308G/A polymorphism with essential hypertension in Han racial origin in Hunan. Chin J Clin Pharmacol Ther 16: 57–60.
- 17. Sookoian S, García SI, Gianotti TF, Dieuzeide G, González CD, et al. (2005) The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with hypertension in adolescents harboring the metabolic syndrome. Am J Hypertens 18: 1271–1275.
- 18. Cochran WG (1968) The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics 24: 295–313.
- 19. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719–748.
- 20. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177–188.
- 21. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 315: 629–634.
- 22. Amer MS, Elawam AE, Khater MS, Omar OH, Mabrouk RA, et al. (2011) Association of high-sensitivity C-reactive protein with carotid artery intima-media thickness in hypertensive older adults. J Am Soc Hypertens 5: 395–400.
- 23. Newhouse SJ, Wallace C, Dobson R, Mein C, Pembroke J, et al. (2005) Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British genetics of hypertension study. Hum Mol Genet 14: 1805–1814.
- 24. Martens FM, Rabelink TJ, op 't Roodt J, de Koning EJ, Visseren FL (2006) TNF-alpha induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-gamma agonist pioglitazone. Eur Heart J 27: 1605–1609.
- 25. Ito H, Ohshima A, Tsuzuki M, Ohto N, Takao K, et al. (2001) Association of serum tumour necrosis factor-alpha with serum low-density lipoprotein-cholesterol and blood pressure in apparently healthy Japanese women. Clin Exp Pharmacol Physiol 28: 188–192.
- 26. Krikovszky D, Vásárhelyi B, Tóth-Heyn P, Körner A, Tulassay T, et al. (2002) Association between G-308A polymorphism of the tumor necrosis factor-alpha gene and 24-hour ambulatory blood pressure values in type 1 diabetic adolescents. Clin Genet 62: 474–477.